1 Osimertinib Market Overview 1.1 Osimertinib Product Overview 1.2 Osimertinib Market Segment by Type 1.2.1 40mg*30 Tablets 1.2.2 80mg*30 Tablets 1.2.3 40mg*10 Tablets 1.2.4 80mg*10 Tablets 1.3 Global Osimertinib Market Size by Type 1.3.1 Global Osimertinib Market Size Overview by Type (2016-2027) 1.3.2 Global Osimertinib Historic Market Size Review by Type (2016-2021) 1.3.2.1 Global Osimertinib Sales Breakdown in Volume by Type (2016-2021) 1.3.2.2 Global Osimertinib Sales Breakdown in Value by Type (2016-2021) 1.3.2.3 Global Osimertinib Average Selling Price (ASP) by Type (2016-2021) 1.3.3 Global Osimertinib Forecasted Market Size by Type (2022-2027) 1.3.3.1 Global Osimertinib Sales Breakdown in Volume by Type (2022-2027) 1.3.3.2 Global Osimertinib Sales Breakdown in Value by Type (2022-2027) 1.3.3.3 Global Osimertinib Average Selling Price (ASP) by Type (2022-2027) 1.4 Key Regions Market Size Segment by Type 1.4.1 North America Osimertinib Sales Breakdown by Type (2016-2021) 1.4.2 Europe Osimertinib Sales Breakdown by Type (2016-2021) 1.4.3 Asia-Pacific Osimertinib Sales Breakdown by Type (2016-2021) 1.4.4 Latin America Osimertinib Sales Breakdown by Type (2016-2021) 1.4.5 Middle East and Africa Osimertinib Sales Breakdown by Type (2016-2021) 2 Global Osimertinib Market Competition by Company 2.1 Global Top Players by Osimertinib Sales (2016-2021) 2.2 Global Top Players by Osimertinib Revenue (2016-2021) 2.3 Global Top Players Osimertinib Price (2016-2021) 2.4 Global Top Manufacturers Osimertinib Manufacturing Base Distribution, Sales Area, Product Type 2.5 Osimertinib Market Competitive Situation and Trends 2.5.1 Osimertinib Market Concentration Rate (2016-2021) 2.5.2 Global 5 and 10 Largest Manufacturers by Osimertinib Sales and Revenue in 2020 2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Osimertinib as of 2020) 2.7 Date of Key Manufacturers Enter into Osimertinib Market 2.8 Key Manufacturers Osimertinib Product Offered 2.9 Mergers & Acquisitions, Expansion 3 Osimertinib Status and Outlook by Region 3.1 Global Osimertinib Market Size and CAGR by Region: 2016 VS 2021 VS 2026 3.2 Global Osimertinib Historic Market Size by Region 3.2.1 Global Osimertinib Sales in Volume by Region (2016-2021) 3.2.2 Global Osimertinib Sales in Value by Region (2016-2021) 3.2.3 Global Osimertinib Sales (Volume & Value) Price and Gross Margin (2016-2021) 3.3 Global Osimertinib Forecasted Market Size by Region 3.3.1 Global Osimertinib Sales in Volume by Region (2022-2027) 3.3.2 Global Osimertinib Sales in Value by Region (2022-2027) 3.3.3 Global Osimertinib Sales (Volume & Value), Price and Gross Margin (2022-2027) 4 Global Osimertinib by Application 4.1 Osimertinib Market Segment by Application 4.1.1 Locally Advanced NSCLC 4.1.2 Metastatic NSCLC 4.1.3 Other 4.2 Global Osimertinib Market Size by Application 4.2.1 Global Osimertinib Market Size Overview by Application (2016-2027) 4.2.2 Global Osimertinib Historic Market Size Review by Application (2016-2021) 4.2.2.1 Global Osimertinib Sales Breakdown in Volume, by Application (2016-2021) 4.2.2.2 Global Osimertinib Sales Breakdown in Value, by Application (2016-2021) 4.2.2.3 Global Osimertinib Average Selling Price (ASP) by Application (2016-2021) 4.2.3 Global Osimertinib Forecasted Market Size by Application (2022-2027) 4.2.3.1 Global Osimertinib Sales Breakdown in Volume, by Application (2022-2027) 4.2.3.2 Global Osimertinib Sales Breakdown in Value, by Application (2022-2027) 4.2.3.3 Global Osimertinib Average Selling Price (ASP) by Application (2022-2027) 4.3 Key Regions Market Size Segment by Application 4.3.1 North America Osimertinib Sales Breakdown by Application (2016-2021) 4.3.2 Europe Osimertinib Sales Breakdown by Application (2016-2021) 4.3.3 Asia-Pacific Osimertinib Sales Breakdown by Application (2016-2021) 4.3.4 Latin America Osimertinib Sales Breakdown by Application (2016-2021) 4.3.5 Middle East and Africa Osimertinib Sales Breakdown by Application (2016-2021) 5 North America Osimertinib by Country 5.1 North America Osimertinib Historic Market Size by Country 5.1.1 North America Osimertinib Sales in Volume by Country (2016-2021) 5.1.2 North America Osimertinib Sales in Value by Country (2016-2021) 5.2 North America Osimertinib Forecasted Market Size by Country 5.2.1 North America Osimertinib Sales in Volume by Country (2022-2027) 5.2.2 North America Osimertinib Sales in Value by Country (2022-2027) 6 Europe Osimertinib by Country 6.1 Europe Osimertinib Historic Market Size by Country 6.1.1 Europe Osimertinib Sales in Volume by Country (2016-2021) 6.1.2 Europe Osimertinib Sales in Value by Country (2016-2021) 6.2 Europe Osimertinib Forecasted Market Size by Country 6.2.1 Europe Osimertinib Sales in Volume by Country (2022-2027) 6.2.2 Europe Osimertinib Sales in Value by Country (2022-2027) 7 Asia-Pacific Osimertinib by Region 7.1 Asia-Pacific Osimertinib Historic Market Size by Region 7.1.1 Asia-Pacific Osimertinib Sales in Volume by Region (2016-2021) 7.1.2 Asia-Pacific Osimertinib Sales in Value by Region (2016-2021) 7.2 Asia-Pacific Osimertinib Forecasted Market Size by Region 7.2.1 Asia-Pacific Osimertinib Sales in Volume by Region (2022-2027) 7.2.2 Asia-Pacific Osimertinib Sales in Value by Region (2022-2027) 8 Latin America Osimertinib by Country 8.1 Latin America Osimertinib Historic Market Size by Country 8.1.1 Latin America Osimertinib Sales in Volume by Country (2016-2021) 8.1.2 Latin America Osimertinib Sales in Value by Country (2016-2021) 8.2 Latin America Osimertinib Forecasted Market Size by Country 8.2.1 Latin America Osimertinib Sales in Volume by Country (2022-2027) 8.2.2 Latin America Osimertinib Sales in Value by Country (2022-2027) 9 Middle East and Africa Osimertinib by Country 9.1 Middle East and Africa Osimertinib Historic Market Size by Country 9.1.1 Middle East and Africa Osimertinib Sales in Volume by Country (2016-2021) 9.1.2 Middle East and Africa Osimertinib Sales in Value by Country (2016-2021) 9.2 Middle East and Africa Osimertinib Forecasted Market Size by Country 9.2.1 Middle East and Africa Osimertinib Sales in Volume by Country (2022-2027) 9.2.2 Middle East and Africa Osimertinib Sales in Value by Country (2022-2027) 10 Company Profiles and Key Figures in Osimertinib Business 10.1 AstraZeneca 10.1.1 AstraZeneca Corporation Information 10.1.2 AstraZeneca Introduction and Business Overview 10.1.3 AstraZeneca Osimertinib Sales, Revenue and Gross Margin (2016-2021) 10.1.4 AstraZeneca Osimertinib Products Offered 10.1.5 AstraZeneca Recent Development 10.2 Incepta Pharmaceuticals Limited 10.2.1 Incepta Pharmaceuticals Limited Corporation Information 10.2.2 Incepta Pharmaceuticals Limited Introduction and Business Overview 10.2.3 Incepta Pharmaceuticals Limited Osimertinib Sales, Revenue and Gross Margin (2016-2021) 10.2.4 AstraZeneca Osimertinib Products Offered 10.2.5 Incepta Pharmaceuticals Limited Recent Development 10.3 Everest Pharmaceuticals 10.3.1 Everest Pharmaceuticals Corporation Information 10.3.2 Everest Pharmaceuticals Introduction and Business Overview 10.3.3 Everest Pharmaceuticals Osimertinib Sales, Revenue and Gross Margin (2016-2021) 10.3.4 Everest Pharmaceuticals Osimertinib Products Offered 10.3.5 Everest Pharmaceuticals Recent Development 10.4 Beacon Pharma 10.4.1 Beacon Pharma Corporation Information 10.4.2 Beacon Pharma Introduction and Business Overview 10.4.3 Beacon Pharma Osimertinib Sales, Revenue and Gross Margin (2016-2021) 10.4.4 Beacon Pharma Osimertinib Products Offered 10.4.5 Beacon Pharma Recent Development 10.5 Drug International 10.5.1 Drug International Corporation Information 10.5.2 Drug International Introduction and Business Overview 10.5.3 Drug International Osimertinib Sales, Revenue and Gross Margin (2016-2021) 10.5.4 Drug International Osimertinib Products Offered 10.5.5 Drug International Recent Development 11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis 11.1 Osimertinib Key Raw Materials 11.1.1 Key Raw Materials 11.1.2 Key Raw Materials Price 11.1.3 Raw Materials Key Suppliers 11.2 Manufacturing Cost Structure 11.2.1 Raw Materials 11.2.2 Labor Cost 11.2.3 Manufacturing Expenses 11.3 Osimertinib Industrial Chain Analysis 11.4 Osimertinib Market Dynamics 11.4.1 Industry Trends 11.4.2 Market Drivers 11.4.3 Market Challenges 11.4.4 Market Restraints 12 Market Strategy Analysis, Distributors 12.1 Sales Channel 12.2 Osimertinib Distributors 12.3 Osimertinib Downstream Customers 13 Research Findings and Conclusion 14 Appendix 14.1 Research Methodology 14.1.1 Methodology/Research Approach 14.1.1.1 Research Programs/Design 14.1.1.2 Market Size Estimation 14.1.1.3 Market Breakdown and Data Triangulation 14.1.2 Data Source 14.1.2.1 Secondary Sources 14.1.2.2 Primary Sources 14.2 Author Details 14.3 Disclaimer

List of Tables Table 1. Major Company of 40mg*30 Tablets Table 2. Major Company of 80mg*30 Tablets Table 3. Major Company of 40mg*10 Tablets Table 4. Major Company of 80mg*10 Tablets Table 5. Global Osimertinib Sales by Type 2016 VS 2021 VS 2027 (US$ Million) Table 6. Global Osimertinib Sales by Type (2016-2021) & (K Pcs) Table 7. Global Osimertinib Sales Market Share in Volume by Type (2016-2021) Table 8. Global Osimertinib Sales by Type (2016-2021) & (US& Million) Table 9. Global Osimertinib Market Share in Value by Type (2016-2021) Table 10. Global Osimertinib Price by Type (2016-2021) & (USD/Pcs) Table 11. Global Osimertinib Sales by Type (2022-2027) & (K Pcs) Table 12. Global Osimertinib Sales Market Share in Volume by Type (2022-2027) Table 13. Global Osimertinib Sales by Type (2022-2027) & (US$ Million) Table 14. Global Osimertinib Sales Market Share in Value by Type (2022-2027) Table 15. Global Osimertinib Price by Type (2022-2027) & (USD/Pcs) Table 16. North America Osimertinib Sales by Type (2016-2021) & (K Pcs) Table 17. North America Osimertinib Sales by Type (2016-2021) & (US$ Million) Table 18. Europe Osimertinib Sales (K Pcs) by Type (2016-2021) Table 19. Europe Osimertinib Sales by Type (2016-2021) & (US$ Million) Table 20. Asia-Pacific Osimertinib Sales (K Pcs) by Type (2016-2021) Table 21. Asia-Pacific Osimertinib Sales by Type (2016-2021) & (US$ Million) Table 22. Latin America Osimertinib Sales (K Pcs) by Type (2016-2021) Table 23. Latin America Osimertinib Sales by Type (2016-2021) & (US$ Million) Table 24. Middle East and Africa Osimertinib Sales (K Pcs) by Type (2016-2021) Table 25. Middle East and Africa Osimertinib Sales by Type (2016-2021) & (US$ Million) Table 26. Global Osimertinib Sales by Company (2016-2021) & (K Pcs) Table 27. Global Osimertinib Sales Share by Company (2016-2021) Table 28. Global Osimertinib Revenue by Company (2016-2021) & (US$ Million) Table 29. Global Osimertinib Revenue Share by Company (2016-2021) Table 30. Global Market Osimertinib Price by Company (2016-2021) & (USD/Pcs) Table 31. Global Osimertinib Top Manufacturers Manufacturing Base Distribution and Sales Area Table 32. Global Osimertinib Manufacturers Market Concentration Ratio (CR5 and HHI) Table 33. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Osimertinib as of 2020 Table 34. Date of Key Manufacturers Enter into Osimertinib Market Table 35. Key Manufacturers Osimertinib Product Type Table 36. Mergers & Acquisitions, Expansion Plans Table 37. Global Osimertinib Market Size Comparison by Region (US$ Million): 2016 VS 2021 VS 2027 Table 38. Global Osimertinib Sales by Region (2016-2021) & (K Pcs) Table 39. Global Osimertinib Sales Market Share in Volume by Region (2016-2021) Table 40. Global Osimertinib Sales by Region (2016-2021) & (US$ Million) Table 41. Global Osimertinib Sales Market Share in Value by Region (2016-2021) Table 42. Global Osimertinib Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021) Table 43. Global Osimertinib Sales by Region (2022-2027) & (K Pcs) Table 44. Global Osimertinib Sales Market Share in Volume by Region (2022-2027) Table 45. Global Osimertinib Sales by Region (2022-2027) & (US$ Million) Table 46. Global Osimertinib Sales Market Share in Value by Region (2022-2027) Table 47. Global Osimertinib Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2022-2027) Table 48. Global Osimertinib Sales by Application: 2016 VS 2021 VS 2027 (US$ Million) Table 49. Global Osimertinib Sales by Application (2016-2021) & (K Pcs) Table 50. Global Osimertinib Sales Market Share in Volume by Application (2016-2021) Table 51. Global Osimertinib Sales by Application (2016-2021) & (US$ Million) Table 52. Global Osimertinib Sales Market Share in Value by Application (2016-2021) Table 53. Global Osimertinib Price by Application (2016-2021) & (USD/Pcs) Table 54. Global Osimertinib Sales by Application (2022-2027) & (K Pcs) Table 55. Global Osimertinib Sales Market Share in Volume by Application (2022-2027) Table 56. Global Osimertinib Sales by Application (2022-2027) & (US$ Million) Table 57. Global Osimertinib Sales Market Share in Value by Application (2022-2027) Table 58. Global Osimertinib Price by Application (2022-2027) & (USD/Pcs) Table 59. North America Osimertinib Sales by Application (2016-2021) (K Pcs) Table 60. North America Osimertinib Sales by Application (2016-2021) & (US$ Million) Table 61. North America Osimertinib Sales Market Share in Value by Application in 2020 Table 62. Europe Osimertinib Sales by Application (2016-2021) (K Pcs) Table 63. Europe Osimertinib Sales by Application (2016-2021) & (US$ Million) Table 64. Europe Osimertinib Sales Market Share in Value by Application in 2020 Table 65. Asia-Pacific Osimertinib Sales by Application (2016-2021) (K Pcs) Table 66. Asia-Pacific Osimertinib Sales by Application (2016-2021) & (US$ Million) Table 67. Asia-Pacific Osimertinib Sales Market Share in Value by Application in 2020 Table 68. Latin America Osimertinib Sales by Application (2016-2021) (K Pcs) Table 69. Latin America Osimertinib Sales by Application (2016-2021) & (US$ Million) Table 70. Latin America Osimertinib Sales Market Share in Value by Application in 2020 Table 71. Middle East and Africa Osimertinib Sales by Application (2016-2021) (K Pcs) Table 72. Middle East and Africa Osimertinib Sales by Application (2016-2021) & (US$ Million) Table 73. Middle East and Africa Osimertinib Sales Market Share in Value by Application in 2020 Table 74. North America Osimertinib Sales by Country (2016-2021) & (K Pcs) Table 75. North America Osimertinib Sales Market Share in Volume by Country (2016-2021) Table 76. North America Osimertinib Sales by Country (2016-2021) & (US$ Million) Table 77. North America Osimertinib Sales Market Share in Value by Country (2016-2021) Table 78. North America Osimertinib Sales by Country (2022-2027) & (K Pcs) Table 79. North America Osimertinib Sales Market Share in Volume by Country (2022-2027) Table 80. North America Osimertinib Sales by Country (2022-2027) & (US$ Million) Table 81. North America Osimertinib Sales Market Share in Value by Country (2022-2027) Table 82. Europe Osimertinib Sales by Country (2016-2021) & (K Pcs) Table 83. Europe Osimertinib Sales Market Share in Volume by Country (2016-2021) Table 84. Europe Osimertinib Sales by Country (2016-2021) & (US$ Million) Table 85. Europe Osimertinib Sales Market Share in Value by Country (2016-2021) Table 86. Europe Osimertinib Sales by Country (2022-2027) & (K Pcs) Table 87. Europe Osimertinib Sales Market Share in Volume by Country (2022-2027) Table 88. Europe Osimertinib Sales by Country (2022-2027) & (US$ Million) Table 89. Europe Osimertinib Sales Market Share in Value by Country (2022-2027) Table 90. Asia-Pacific Osimertinib Sales by Region (2016-2021) & (K Pcs) Table 91. Asia-Pacific Osimertinib Sales Market Share in Volume by Region (2016-2021) Table 92. Asia-Pacific Osimertinib Sales by Region (2016-2021) & (US$ Million) Table 93. Asia-Pacific Osimertinib Sales Market Share in Value by Region (2016-2021) Table 94. Asia-Pacific Osimertinib Sales by Region (2022-2027) & (K Pcs) Table 95. Asia-Pacific Osimertinib Sales Market Share in Volume by Region (2022-2027) Table 96. Asia-Pacific Osimertinib Sales by Region (2022-2027) & (US$ Million) Table 97. Asia-Pacific Osimertinib Sales Market Share in Value by Region (2022-2027) Table 98. Latin America Osimertinib Sales by Country (2016-2021) & (K Pcs) Table 99. Latin America Osimertinib Sales Market Share in Volume by Country (2016-2021) Table 100. Latin America Osimertinib Sales by Country (2016-2021) & (US$ Million) Table 101. Latin America Osimertinib Sales Market Share in Value by Country (2016-2021) Table 102. Latin America Osimertinib Sales by Country (2022-2027) & (K Pcs) Table 103. Latin America Osimertinib Sales Market Share in Volume by Country (2022-2027) Table 104. Latin America Osimertinib Sales by Country (2022-2027) & (US$ Million) Table 105. Latin America Osimertinib Sales Market Share in Value by Country (2022-2027) Table 106. Middle East and Africa Osimertinib Sales by Country (2016-2021) & (K Pcs) Table 107. Middle East and Africa Osimertinib Sales Market Share in Volume by Country (2016-2021) Table 108. Middle East and Africa Osimertinib Sales by Country (2016-2021) & (US$ Million) Table 109. Middle East and Africa Osimertinib Sales Market Share in Value by Country (2016-2021) Table 110. Middle East and Africa Osimertinib Sales by Country (2022-2027) & (K Pcs) Table 111. Middle East and Africa Osimertinib Sales Market Share in Volume by Country (2022-2027) Table 112. Middle East and Africa Osimertinib Sales by Country (2022-2027) & (US$ Million) Table 113. Middle East and Africa Osimertinib Sales Market Share in Value by Country (2022-2027) Table 114. AstraZeneca Corporation Information Table 115. AstraZeneca Introduction and Business Overview Table 116. AstraZeneca Osimertinib Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021) Table 117. AstraZeneca Osimertinib Product Table 118. AstraZeneca Recent Development Table 119. Incepta Pharmaceuticals Limited Corporation Information Table 120. Incepta Pharmaceuticals Limited Introduction and Business Overview Table 121. Incepta Pharmaceuticals Limited Osimertinib Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021) Table 122. Incepta Pharmaceuticals Limited Osimertinib Product Table 123. Incepta Pharmaceuticals Limited Recent Development Table 124. Everest Pharmaceuticals Corporation Information Table 125. Everest Pharmaceuticals Introduction and Business Overview Table 126. Everest Pharmaceuticals Osimertinib Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021) Table 127. Everest Pharmaceuticals Osimertinib Product Table 128. Everest Pharmaceuticals Recent Development Table 129. Beacon Pharma Corporation Information Table 130. Beacon Pharma Introduction and Business Overview Table 131. Beacon Pharma Osimertinib Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021) Table 132. Beacon Pharma Osimertinib Product Table 133. Beacon Pharma Recent Development Table 134. Drug International Corporation Information Table 135. Drug International Introduction and Business Overview Table 136. Drug International Osimertinib Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021) Table 137. Drug International Osimertinib Product Table 138. Drug International Recent Development Table 139. Key Raw Materials Lists Table 140. Raw Materials Key Suppliers Lists Table 141. Osimertinib Market Trends Table 142. Osimertinib Market Drivers Table 143. Osimertinib Market Challenges Table 144. Osimertinib Market Restraints Table 145. Osimertinib Distributors List Table 146. Osimertinib Downstream Customers Table 147. Research Programs/Design for This Report Table 148. Key Data Information from Secondary Sources Table 149. Key Data Information from Primary Sources List of Figures Figure 1. Osimertinib Product Picture Figure 2. Global Osimertinib Market Size, 2016 VS 2021 VS 2027 (US$ Million) Figure 3. Global Osimertinib Market Size Status and Outlook (2016-2027) & (US$ Million) Figure 4. Global Osimertinib Sales Status and Outlook (2016-2027) & (K Pcs) Figure 5. Product Picture of 40mg*30 Tablets Figure 6. Global 40mg*30 Tablets Sales YoY Growth (2016-2021) & (K Pcs) Figure 7. Product Picture of 80mg*30 Tablets Figure 8. Global 80mg*30 Tablets Sales YoY Growth (2016-2021) & (K Pcs) Figure 9. Product Picture of 40mg*10 Tablets Figure 10. Global 40mg*10 Tablets Sales YoY Growth (2016-2021) & (K Pcs) Figure 11. Product Picture of 80mg*10 Tablets Figure 12. Global 80mg*10 Tablets Sales YoY Growth (2016-2021) & (K Pcs) Figure 13. Global Osimertinib Sales by Type (2016-2027) & (US$ Million) Figure 14. Global Osimertinib Sales Market Share in Volume by Type (2016-2021) Figure 15. Global Osimertinib Sales Market Share in Value by Type (2016-2021) Figure 16. Global Osimertinib Sales Market Share in Volume by Type (2022-2027) Figure 17. Global Osimertinib Sales Market Share in Value by Type (2022-2027) Figure 18. North America Osimertinib Sales Market Share in Volume by Type in 2020 Figure 19. North America Osimertinib Sales Market Share in Value by Type in 2020 Figure 20. Europe Osimertinib Sales Market Share in Volume by Type in 2020 Figure 21. Europe Osimertinib Sales Market Share in Value by Type in 2020 Figure 22. Asia-Pacific Osimertinib Sales Market Share in Volume by Type in 2020 Figure 23. Asia-Pacific Osimertinib Sales Market Share in Value by Type in 2020 Figure 24. Latin America Osimertinib Sales Market Share in Volume by Type in 2020 Figure 25. Latin America Osimertinib Sales Market Share in Value by Type in 2020 Figure 26. Middle East and Africa Osimertinib Sales Market Share in Volume by Type in 2020 Figure 27. Middle East and Africa Osimertinib Sales Market Share in Value by Type in 2020 Figure 28. The 5 and 10 Largest Manufacturers in the World: Market Share by Osimertinib Sales in 2020 Figure 29. The 5 and 10 Largest Manufacturers in the World: Market Share by Osimertinib Revenue in 2020 Figure 30. Osimertinib Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2016 VS 2020 Figure 31. Product Picture of Locally Advanced NSCLC Figure 32. Global Locally Advanced NSCLC Sales YoY Growth (2016-2027) & (K Pcs) Figure 33. Product Picture of Metastatic NSCLC Figure 34. Global Metastatic NSCLC Sales YoY Growth (2016-2027) & (K Pcs) Figure 35. Product Picture of Other Figure 36. Global Other Sales YoY Growth (2016-2027) & (K Pcs) Figure 37. Global Osimertinib Sales by Application (2016-2027) & (US$ Million) Figure 38. Global Osimertinib Sales Market Share in Volume by Application (2016-2021) Figure 39. Global Osimertinib Sales Market Share in Value by Application (2016-2021) Figure 40. Global Osimertinib Sales Market Share in Volume by Application (2022-2027) Figure 41. North America Osimertinib Sales Market Share in Volume by Application in 2020 Figure 42. Latin America Osimertinib Sales Market Share in Value by Application in 2020 Figure 43. Middle East and Africa Osimertinib Sales Market Share in Value by Application in 2020 Figure 44. Key Raw Materials Price Figure 45. Osimertinib Manufacturing Cost Structure Figure 46. Osimertinib Industrial Chain Analysis Figure 47. Channels of Distribution Figure 48. Distributors Profiles Figure 49. Bottom-up and Top-down Approaches for This Report Figure 50. Data Triangulation Figure 51. Key Executives Interviewed

AstraZeneca Incepta Pharmaceuticals Limited Everest Pharmaceuticals Beacon Pharma Drug International